Tradestie Institutional Equity Comparison Engine
PUSA vs ACA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACA Overall Edge
ACA Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcosa, Inc. Common Stock (ACA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PUSA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACA at 29.1x Forward P/E and 12.3% operating margin (+1.7% YoY). In options structure, PUSA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACA sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ACA
PUSA N/M vs ACA 29.1x Fwd P/E
Growth & Margin Winner
ACA
Op Margin N/A vs 12.3% ยท YoY N/A vs +1.7%
Momentum & Technical Winner
ACA
1Y -74.0% vs +57.4% ยท 52W Pos 2% vs 100%
Options & Structure Winner
ACA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
PUSA
US Equity
PUSA
Institutional Equity
$1.12
+0.9% 1D
Market Cap
N/A
1M Return
-42.6%
1Y Return
-74.02%
Forward P/E
N/M
Unified AI Score
38.8 / 100
SELL
Tech 25.0
Fund 43.0
Flow 50.0
Mom 59.0
ACA
NYSE
Arcosa, Inc. Common Stock
Fabricated Structural Metal Products
$149.15
+0.08% 1D
Market Cap
$7.3B
1M Return
+1.81%
1Y Return
+57.43%
Forward P/E
29.1x
Unified AI Score
60.0 / 100
BUY
Tech 56.0
Fund 49.0
Flow 50.0
Mom 36.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PUSA -74.02%
ACA +57.43%
Spread: +76.86 pp (ACA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PUSA TTM Op. Margin: N/A
ACA TTM Op. Margin: 12.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PUSA vs ACA. Trailing 12-month operating profitability (PUSA N/A vs ACA 12.3%) and valuation multiples (PUSA N/M vs ACA 29.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PUSA | ACA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $7.3B | Larger Scale | ACA |
| Trailing P/E Ratio Valuation | N/M | 36.4x | Lower Multiple | ACA |
| Forward P/E Ratio Valuation | N/M | 29.1x | Lower Multiple | ACA |
| Revenue Growth (YoY) Growth | N/A | +1.7% | Higher Growth | ACA |
| Operating Margin (TTM) Profitability | N/A | 12.3% | Higher Margin | ACA |
| Net Profit Margin Profitability | N/A | 16.8% | Higher Margin | ACA |
| Return on Equity (ROE) Capital Efficiency | N/A | 8.0% | Higher ROE | ACA |
| 52-Week Range Position Momentum | 2% ($1โ$7) | 100% ($91โ$149) | Stronger Trend | ACA |
| Beta / 30D Volatility Risk Regime | 1.56ฮฒ ยท 105% Vol | 0.92ฮฒ ยท 4% Vol | Lower Realized Risk | ACA |
| Unified Institutional Score Composite Signal | 38.8 / 100 (SELL) | 60.0 / 100 (BUY) | Higher Composite | ACA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PUSA vs ACA Buy Guide
PUSA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ACA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PUSA nor ACA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.